Decreased activity of the striatum, resulting in less dopaminergic activity does not necessarily equate to a clinical implication. Physiological differences can be presented for a variety of reasons and do not necessarily correspond to illness. Furthermore, the overlap of results between control groups and experimental groups can suggest that despite the decreased activity of the striatum, the dopaminergic differences of drug users (such as methamphetamine users) are not clinically significant.